Modulation of neural cell membrane conductance by the herbal anxiolytic and antiepileptic drug aswal by Grunze, Heinz et al.
Neuropsychobiology 2000;42(suppl 1):28–32
Modulation of Neural Cell Membrane
Conductance by the Herbal Anxiolytic
and Antiepileptic Drug Aswal
H. Grunzea J. Langoschb C. von Loewenicha J. Waldenb
aDepartment of Psychiatry, LMU University Hospital, Munich, and bDepartment of Psychiatry, University Hospital,
Freiburg i.Br., Germany
Dr. med. H. Grunze
Department of Psychiatry, LMU Munich
Nussbaumstrasse 7
D–80336 Munich (Germany)
Tel. +49 89 5160 5335, Fax +49 89 5160 5330, E-Mail grunze@psy.med.uni-muenchen.de
ABC
Fax + 41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
© 2000 S. Karger AG, Basel
0302–282X/00/0425–0028$17.50/0
Accessible online at:
www.karger.com/journals/nps
Key Words
Aswal W Anticonvulsant W Calciumantagonism W Anxiety W
Bipolar disorder
Abstract
To evaluate the effects of aswal on ionic fluxes and neu-
ronal excitation, we performed extracellular and whole
cell patch clamp recordings on CA1 pyramidal neu-
rons of guinea pigs and Long-Evans rats. Aswal (100–
250 mg/l) was administered systemically, and its effects
on the rate of synchronized extracellular field potentials
(EFP), membrane parameters, action potentials and
postsynaptic potentials were recorded. The extracellular
results obtained are consistent with calcium antagonistic
properties. Intracellular recordings suggest that a direct
sodium antagonistic effect as seen in many antiepileptic
drugs plays no significant role. Further effects on ligand
gated ion channels are discussed controversially. In
summary, the cellular action of aswal appears heteroge-
neous with calcium antagonism playing a prominent
role in counteracting excitation which may be a common
feature in epilepsy and different psychiatric conditions as
mood and anxiety disorder. 
Copyright © 2000 S. Karger AG, Basel
Introduction
Herbal remedies such as St John’s wort play an increas-
ing role in modern Western medicine due to their popular
demand by patients. Traditional experience and small
clinical trials suggest efficacy mostly in minor states of
anxiety, depressed mood and sleep disturbances. Besides
this, two drugs have also demonstrated anticonvulsant
activity, thus making them obviously potent CNS depres-
sant substances: The kava-pyrone kawain and aswal, pre-
pared from dried roots of Withania somnifera, a tradi-
tional Indian remedy which has recently been released in
Switzerland. For kawain, we previously described its
effects on ionic membrane fluxes [1, 2].
W. somnifera (winter cherry) is an indigenous plant of
India. Constituents of the plant, roots and leaves, are
widely used in Ayurveda and Siddha medicine as a seda-
tive and aphrodisiac. It has also been traditionally used in
treating epilepsy. Furthermore, a variety of cerebral and
immunomodulatory (antitumor) effects have been de-
scribed [3, 4]. Antioxidant effect of active components of
W. somnifera may explain, at least in part, the report-
ed antistress, immunomodulatory, cognition-facilitating,
anti-inflammatory and antiaging effects produced by
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them in experimental animals [5]. In behavioral tests,
antistressor capabilities of aswal have been described [6];
with chemical stressors, simultaneous oral administration
of ashwagandha (100 mg/kg) prevents the rise in lipid
peroxidation in stressed rabbits and mice after intrave-
nous administration of 0.2 Ìg/kg of lipopolysaccharide
from Klebsiella pneumoniae and 100 Ìg/kg of peptidogly-
can from Staphylococcus aureus [7].
At least on the behavioral side, a common mechanism
producing these effects can be a modulation of membrane
ion channel function, similar to kava-pyrones. To further
evaluate the effects of aswal on ionic fluxes and neuronal
excitation, we performed the following experiments.
Methods
Extracellular Recordings
The experiments were carried out in hippocampal slices of guinea
pigs (300–400 m thick). The brain was removed from the guinea pig
under ether anesthesia. The slices were preincubated for 2 h in a
28°C standard saline containing (in mmol/l) NaCl 124, KCl 4, CaCl2
0.75, KH2PO4 1.24, MgCl2 1.3, NaHCO3 26 and glucose 10, and
which was equilibrated with 5% CO2 in O2 (carbogen). After preincu-
bation, the slices were transferred to a recording chamber which was
continuously (2 ml/min) superfused by 32°C saline. The ionic com-
position was the same as during preincubation except for the Ca2+
concentration which was raised from 0.75 to 1.75 mmol/l and the K+
concentration which was augmented from 4 to 8 mmol/l [8, 9]. Slices
were perfused for a minimum of 1 h with this standard solution
before switching to the zero Mg2+ solution. The pH of the carbogen-
equilibrated saline was 7.4 and did not change when MgCl2 was
omitted or when drugs were added to the saline. Aswal (100–
250 mg/l) was dissolved in DMSO in a concentration of 0.1% which
had no effects on the tested field potentials by itself.
Extracellular recording were performed from stratum pyramidale
of CA1 and CA3 areas of the hippocampal slice using glass microelec-
trodes (resistance was in the range of 1–3 Mø) filled with 2 mol/l
NaCl. Signals were amplified by a conventional microelectrode am-
plifier (NPI electronics, Tamm, Germany), stored on an oscilloscope
and plotted on a pen recorder.
Intracellular Recordings
Whole cell patch clamp recordings from the CA1 region of rat
hippocampal slices were performed. A bipolar stimulus electrode was
placed in the stratum radiatum. Slices were prepared from rats of
both genders, aged 25–40 days, and maintained using standard pro-
cedures. Rats were decapitated under halothane anesthesia, the
brains were rapidly removed, and 300- to 400-Ìm-thick transverse
slices were cut from the hippocampus with a vibratome (Model 820;
Spencer Inc.). Slices were then placed in oxygenated artificial cere-
brospinal fluid at room temperature. Whole cell recordings were
obtained with the technique of Blanton et al. [10]. Briefly, borosili-
cate glass electrodes (resistance 4–6 Mø) were filled with 100 mM
potassium citrate, 20 mM KCl, 1 mM CaCl2, 3 mM MgCl2, 2 mM
MgATP, 2 mM NaGTP, 3 mM EGTA and 40 mM Hepes. Record-
ings were made with an Axopatch 200A amplifier (Axon Instru-
Fig. 1. Graphic presentation of the reduc-
tion in the frequency of EPS in the hippo-
campus by aswal (100 mg/l).
ments, Burlingame, Calif., USA) using the p-clamp 6.0 software.
Artificial cerebrospinal fluid contained (in mM ): NaCl 124; KCl
3.75; KH2PO4 1.25; MgCl2 1.3; CaCl2 3.5; NaHCO3 26, glucose 10;
bubbled with 95% O2-5% CO2 and maintained at 30 B 2°C
throughout the recordings.
Results
Extracellular Recordings
During perfusion of the slice with a zero Mg2+ solution,
typical field potentials developed within a few minutes,
being the correlate of intracellularly recorded paroxysmal
depolarization shifts [11]. Several investigations have
shown that calcium currents essentially contribute to the
generation of these EFP [8, 9, 12]. There is no difference
in the frequency of occurrence of EFP between CA3 and
CA1 regions of the hippocampal slice [12]
The systemic administration of aswal (100 mg/l) with
the zero Mg2+ solution resulted in a reduction in the repe-
tition rate of field potentials of 56% after 30 min (fig. 1)
Intracellular Recordings
Stable whole cell patch clamp recordings were estab-
lished using standard methods. Only cells with a resting
membrane potential between –58 and –65 mV and an
input resistance of 50–100 Mø were used. Stability of
these parameters was checked several times during a 15-
min baseline recording. Cells were classified as pyrami-
dal-type cells by their electrophysiological properties, in-
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Fig. 2. Reduction in AP frequency in response to a depolarizing current injection. a Baseline. b During superfusion
with aswal (250 mg/l) for 15 min. c After 30 min aswal. d After 15 min washout.
cluding action potential duration and spike accommoda-
tion with repetitive firing. Aswal (100 or 250 mg/l) was
added to the superfusate for 30 min, followed by a 15-min
washout period.
We found that:
(1) The resting membrane potential, action potential
(AP) threshold and input resistance remained unchanged
with aswal in both concentrations tested (100 and
250 mg/l).
(2) When repetitive AP firing was elicited by injecting
currents from 150 to 450 pA, the effect of aswal on repeti-
tive firing in response to current injection was heteroge-
neous; 2/5 cells showed a small reduction (fig. 2), 2/5 an
increase of the frequency, and 1/5 was not affected. The
AP amplitude remained unchanged in all cells.
(3) Finally, excitatory (EPSP) and inhibitory (IPSP)
postsynaptic potentials were evoked by stimulation of the
stratum radiatum. Recording postsynaptic potential in 5
cells, we saw in 4/5 cells a 38 B 20% reduction in the
EPSP with aswal, but no effect on IPSP expression
(fig. 3).
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Fig. 3. Reduction in the EPSP amplitude. a Baseline. b Aswal 100 mg/l. c After 15 min washout.
Discussion
The zero-Mg2+-induced field potential changes are
thought to be generated due to the unblocking of NMDA
receptors and the following activation of voltage-depen-
dent calcium channels [8, 12–14]. Moreover, they are
blocked by organic calcium channel blockers [9, 12]. Our
extracellular results are also consistent with calcium an-
tagonistic properties of aswal. As a fact, calcium antago-
nists are effective antiepileptic drugs in vitro and can
exert mood-stabilizing properties in patients [15]. Thus,
calcium antagonism may be an mechanism underlying
the action of aswal. Similar to anticonvulsants with cal-
cium antagonistic features, and to nimodipine, aswal
exerts also antikindling properties in vivo [16]. Our intra-
cellular recordings showing no reproducible reduction in
repetitive AP firing and AP amplitude suggest that a
direct sodium antagonistic effect as seen in many antiepi-
leptic drugs plays no significant role.
GABAergic properties mediated through the barbitu-
rate binding site have been implicated for the antiepilep-
tic potency of aswal [17]. In our experiments, however,
the stability of the resting membrane potential while
aswal was administered makes at least a strong GABAer-
gic component of its action unlikely, as direct application
of GABA or its agonists drag the resting membrane poten-
tial towards more negative potentials. The lack of acute,
strong GABA agonistic properties is also supported by the
lack of changes in the IPSP following stratum radiatum
stimulation. These results are supported by histochemical
results of Schliebs et al. [18], showing effects on acetylcho-
linesterase, but not on glutamatergic or GABAergic mark-
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ers. The observed EPSP reduction can also be related to
the calciumantagonistic properties and not necessarily to
antiglutamatergic mechanisms.
Taken together, the cellular actions of aswal appear
heterogeneous with calcium antagonism playing a promi-
nent role in counteracting excitation. A role of increased
intracellular calcium concentration has been implied for
such different conditions as epilepsy, alcohol withdrawal,
bipolar disorder and anxiety. Thus, aswal may be a poten-
tially effective drug for these disorder. At least on the cel-
lular level, aswal seems to have a profile of action which
can justify a further follow-up of its efficacy for mood dis-
order in controlled trials.
Acknowledgements
This study was supported in part by the Deutsche Forschungsge-
meinschaft (DFG; GR 1264/4-1) and in part by the Vada and Theo-
dore Stanley Foundation.
References
1 Walden J, von Wegerer J, Winter U, Berger M,
Grunze H: Effects of kawain and dihydrome-
thysticin on field potential changes in the hip-
pocampus. Prog Neuropsychopharmacol Biol
Psychiatry 1997;21:697–706.
2 Grunze H, Walden, J: Kawain limits excitation
in CA1 pyramidal neurons of rats by modulat-
ing ionic currents and attenuating excitatory
postsynaptic transmission. Hum Psychophar-
macol Clin Exp 1999;14:63–66.
3 Rege NN, Thatte UM, Dahanukar SA: Adap-
togenic properties of six rasayana herbs used in
Ayurvedic medicine. Phytother Res 1999;13:
275–291.
4 Ziauddin M, Phansalkar N, Patki P, Diwanay
S, Patwardhan B: Studies on the immunomo-
dulatory effects of Ashwagandha. J Ethnophar-
macol 1996;50:69–76.
5 Bhattacharya SK, Satyan KS, Ghosal S: An-
tioxidant activity of glycowithanolides from
Withania somnifera. Indian J Exp Biol 1997;
35:236–239.
6 Archana R, Namasivayam A: Antistressor ef-
fect of Withania somnifera. J Ethnopharmacol
1999;64:91–93.
7 Dhuley JN: Effect of ashwagandha on lipid
peroxidation in stress-induced animals. J Eth-
nopharmacol 1998;60:173–178.
8 Bingmann D, Speckmann EJ: Specific suppres-
sion of pentylenetetrazol induced epileptiform
discharges in CA3 neurons by the organic cal-
cium antagonists flunarizine and verapamil.
Exp Brain Res 1988;74:239–248.
9 Walden J, Grunze H, Mayer A, Düsing R,
Schirrmacher K, Liu Z, Bingmann D: Calcium-
antagonistic effects of carbamazepine in epi-
lepsies and affective psychoses. Neuropsycho-
biology 1993;27:171–175.
10 Blanton MG, Lo Turco JJ, Kriegstein AR:
Whole cell recording from neurons in slices of
reptilian and mammalian cerebral cortex. J
Neurosci Methods 1989;30:203–210.
11 Schmitz D, Zhang CL, Chatterjee SS, Heine-
mann U: Effects of methysticin on three differ-
ent models of seizure like events studied in rat
hippocampal and entorhinal cortex slices. Nau-
nyn Schmiedebergs Arch Pharmacol 1995;351:
348–355.
12 Pohl M, Straub H, Speckmann EJ: Low-magne-
sium induced epileptic discharges in guinea pig
hippocampal slices: Depression by the organic
calcium antagonist verapamil. Brain Res 1992;
577:29–35.
13 Walther H, Lambert JD, Jones RS, Heinemann
U, Hamon B: Epileptiform activity in com-
bined slices of the hippocampus, subiculum
and entorhinal cortex during perfusion with
low magnesium medium. Neurosci Lett 1986;
69:156–161.
14 Mody I, Lambert JD, Heinemann U: Low ex-
tracellular magnesium induces epileptiform ac-
tivity and spreading depression in rat hippo-
campal slices. J Neurophysiol 1987;57:869–
888.
15 Langosch JM, Walden J: Bedeutung kalzi-
umantagonistischer Effekte für die medika-
mentöse Therapie affektiver Störungen.
Fortschr Neurol Psychiatry 1998;66:570–579.
16 Kulkarni SK, George B, Nayar U: Amygdaloid
kindling in rats: Protective effect of Withania
somnifera (Aswagandha) root extract. Indian
Drugs 1995;32:37–49.
17 Kulkarni SK, Sharma A, Verma A, Ticku, MK:
GABA receptor mediated anticonvulsant ac-
tion of Withania somnifera root extract. Indian
Drugs 1993;30:305–312.
18 Schliebs R, Liebmann, A, Bhattacharya SK,
Kumar A, Ghosal S, Bigl V: Systemic adminis-
tration of defined extracts from Withania som-
nifera (Indian Ginseng) and Shilajit differen-
tially affects cholinergic but not glutamatergic
and GABAergic markers in rat brain. Neuro-
chem Int 1997;30:181–190.
